A study highlights the impact of next-generation sequencing (NGS) on the management of inborn errors of immunity in Australasia. The findings suggest that NGS significantly alters clinical management strategies for these rare conditions.
management change following ngs diagnosis of inborn errors of immunity the australasian experience
Original title: “Management change following NGS diagnosis of inborn errors of immunity: The Australasian experience.”